Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,452 | 518 | 81.1% |
| Travel and Lodging | $1,878 | 13 | 18.0% |
| Gift | $59.40 | 1 | 0.6% |
| Education | $36.03 | 2 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic, Inc. | $1,990 | 42 | $0 (2024) |
| Novo Nordisk Inc | $1,552 | 115 | $0 (2024) |
| Medtronic MiniMed, Inc. | $870.12 | 16 | $0 (2020) |
| Lilly USA, LLC | $849.54 | 53 | $0 (2024) |
| Dexcom, Inc. | $722.74 | 51 | $0 (2024) |
| Abbott Laboratories | $717.10 | 43 | $0 (2024) |
| Amgen Inc. | $402.55 | 24 | $0 (2024) |
| Xeris Pharmaceuticals, Inc. | $346.45 | 19 | $0 (2024) |
| Merck Sharp & Dohme LLC | $304.98 | 22 | $0 (2023) |
| Radius Health, Inc. | $302.38 | 17 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,033 | 111 | Lilly USA, LLC ($318.45) |
| 2023 | $1,643 | 96 | Novo Nordisk Inc ($302.56) |
| 2022 | $2,435 | 113 | Medtronic, Inc. ($1,137) |
| 2021 | $2,071 | 107 | Medtronic, Inc. ($694.88) |
| 2020 | $603.83 | 46 | Novo Nordisk Inc ($161.69) |
| 2019 | $551.64 | 35 | Novo Nordisk Inc ($122.60) |
| 2018 | $1,088 | 26 | Medtronic MiniMed, Inc. ($806.25) |
All Payment Transactions
534 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Neurocrine Biosciences, Inc. | CRENESSITY (Drug) | Food and Beverage | In-kind items and services | $30.58 | General |
| Category: Neuropsychiatry | ||||||
| 12/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $9.06 | General |
| Category: Diabetes | ||||||
| 12/13/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: Diabetes | ||||||
| 12/11/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 12/11/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.20 | General |
| Category: Diabetes | ||||||
| 12/10/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: Rare Disease | ||||||
| 12/10/2024 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $12.33 | General |
| Category: Diabetes Care | ||||||
| 12/09/2024 | RECORDATI_RARE_DISEASES_INC. | ISTURISA (Drug) | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: ENDOCRINE AGENT | ||||||
| 12/04/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 12/02/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: DIABETES | ||||||
| 11/27/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: Endocrinology | ||||||
| 11/26/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 11/25/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: Diabetes Care | ||||||
| 11/25/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $7.64 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | Sequel Med Tech, LLC | — | Food and Beverage | In-kind items and services | $27.26 | General |
| 11/20/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/19/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $16.50 | General |
| Category: Insulin Pump | ||||||
| 11/18/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: Diabetes | ||||||
| 11/15/2024 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: Endocrinology | ||||||
| 11/13/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $23.14 | General |
| 11/13/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: Durable Pump | ||||||
| 11/10/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: Cardiology | ||||||
| 11/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $8.20 | General |
| Category: Diabetes | ||||||
| 11/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 310 | 503 | $95,431 | $31,596 |
| 2022 | 5 | 401 | 602 | $114,489 | $38,305 |
| 2021 | 5 | 393 | 591 | $119,742 | $41,903 |
| 2020 | 3 | 390 | 610 | $118,460 | $43,163 |
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 183 | 362 | $66,628 | $24,377 | 36.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 67 | 67 | $20,525 | $5,283 | 25.7% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Facility | 2023 | 23 | 36 | $3,600 | $938.99 | 26.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 12 | 12 | $1,428 | $505.80 | 35.4% |
| 76536 | Ultrasound scan of head and neck soft tissue | Facility | 2023 | 25 | 26 | $3,250 | $491.41 | 15.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 247 | 421 | $77,623 | $27,728 | 35.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 67 | 67 | $20,525 | $6,118 | 29.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 23 | 24 | $6,566 | $2,400 | 36.6% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Facility | 2022 | 36 | 59 | $5,900 | $1,458 | 24.7% |
| 76536 | Ultrasound scan of head and neck soft tissue | Facility | 2022 | 28 | 31 | $3,875 | $601.05 | 15.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 206 | 389 | $72,305 | $27,725 | 38.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 102 | 102 | $31,008 | $9,780 | 31.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 26 | 30 | $7,620 | $2,926 | 38.4% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Facility | 2021 | 19 | 29 | $2,900 | $759.36 | 26.2% |
| 76536 | Ultrasound of head and neck | Facility | 2021 | 26 | 27 | $3,375 | $560.30 | 16.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 14 | 14 | $2,534 | $152.53 | 6.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 211 | 402 | $73,407 | $28,599 | 39.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 101 | 130 | $24,261 | $7,812 | 32.2% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 49 | 49 | $14,898 | $5,270 | 35.4% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 12 | 12 | $3,805 | $1,150 | 30.2% |
| 76536 | Ultrasound of head and neck | Office | 2020 | 17 | 17 | $2,089 | $331.81 | 15.9% |
About Dr. Heather Corn, MD
Dr. Heather Corn, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Florence, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/27/2011. The National Provider Identifier (NPI) number assigned to this provider is 1396036109.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Heather Corn, MD has received a total of $10,425 in payments from pharmaceutical and medical device companies, with $2,033 received in 2024. These payments were reported across 534 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($8,452).
As a Medicare-enrolled provider, Corn has provided services to 1,494 Medicare beneficiaries, totaling 2,306 services with total Medicare billing of $154,968. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism|Student in an Organized Health Care Education/Training Program|Endocrinology, Diabetes & Metabolism
- Location Florence, KY
- Active Since 04/27/2011
- Last Updated 04/22/2024
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1396036109
Products in Payments
- INPEN SMART INSULIN DELIVERY SYSTEM (Device) $1,118
- Ozempic (Drug) $942.45
- Minimed 670G System (Device) $865.72
- InPen (Device) $690.42
- Dexcom G6 Transmitter (Medical Supply) $510.26
- FREESTYLE LIBRE (Device) $492.32
- JARDIANCE (Drug) $383.30
- Rybelsus (Drug) $322.72
- TRULICITY (Drug) $266.12
- JANUVIA (Drug) $208.65
- Tymlos (Biological) $206.63
- Wegovy (Drug) $195.70
- MOUNJARO (Drug) $195.33
- FreeStyle Libre (Device) $190.60
- Kerendia (Drug) $190.48
- EVENITY (Biological) $187.16
- ISTURISA (Drug) $178.84
- DEXCOM G6 TRANSMITTER (Device) $170.47
- GVOKE PFS (Drug) $168.44
- FARXIGA (Drug) $150.48
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Florence
Bradley Eilerman, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $1.5M
Dr. Peter Butler, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $216,269
Gerald Miele, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $153,543
Dr. Bethany Jackson, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $127,544
Jamie Brewer, Np, NP
Endocrinology, Diabetes & Metabolism — Payments: $6,298
Meenakshi Pande, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $6,081